Peer-led Personalized Support Program
Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 15, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new support program designed to help young people who have been struggling with drug abuse. The program uses instant messaging to connect participants with trained peer supporters who can provide personalized guidance and encouragement. The goal is to see if this approach can help participants quit using drugs and improve their overall quality of life over a year.
To join the study, participants need to be 35 years old or younger, speak Cantonese, and have a history of drug abuse within the last year. Peer supporters, who will also be involved in the program, must be between 18 and 35 years old, have a medical background, and complete specific training. Throughout the trial, participants can expect to receive support from peers who understand their challenges, and the study aims to find out if this kind of help makes a real difference in their recovery journey.
Gender
ALL
Eligibility criteria
- The inclusion criteria of target service group (drug abusers) for this programme:
- • be aged 35 or below
- • be able to communicate in Cantonese
- • have an history of drug abuse within the past 12 months (including all types of drugs such as narcotics analgesics, hallucinogens, depressants, stimulants, tranquillizers and other recreational drugs)
- The exclusion Criteria of target service group (drug abusers) for this programme:
- • psychologically or physically unable to communicate
- The inclusion criteria of peer supporters:
- • be aged 18 - 35
- • be able to communicate in Cantonese
- • have a medical background
- • complete the training courses and pass the evaluation of peer supporter qualification
- The exclusion Criteria of peer supporters:
- • psychologically or physically unable to communicate
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Ho Cheung William Li
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported